DaVita (DVA) stock experienced a decline of 0.97% likely due to market fluctuations or specific investor sentiment reflecting concerns in the healthcare and dialysis sectors, but the article primarily focused on Vystar Corporation's new UV-C air purification product and did not provide detailed information on DaVita's stock movement.

DaVita (DVA) stock experienced a decline of 0

DaVita Inc. (NYSE:DVA) stock increased by 0.28% following a notable boost in institutional buying, particularly by Victory Capital Management Inc., which raised its stake by 31.9%, signaling investor confidence in the company's performance and potential.

DaVita Inc

The article reports that DaVita (DVA) stock dropped 4.33% due to Berkshire Hathaway's decision to reduce its stake in the company as part of a broader move to sell off parts of its portfolio, including significant divestments from various financial institutions.

The article reports that DaVita (DVA) stock dropped 4

DaVita Inc. (DVA) stock increased by 4.75% due to positive earnings that exceeded analyst expectations, alongside significant trading activity from institutional investors modifying their stakes in the company.

DaVita Inc. (DVA) stock decreased by 1.23% and currently has an average recommendation of "Hold" from analysts, partly due to a recently lowered price target by Truist Financial and the overall cautious sentiment among multiple research firms assessing the stock's potential.

DaVita Inc. (DVA) stock decreased by 0.22% due to Xponance Inc. reducing its holdings in the company and various hedge funds modifying their positions, with ongoing analyst reports suggesting a cautious outlook for the stock.

DaVita Inc. (DVA) stock was down 0.22% due to a combination of analyst rating adjustments, with Truist Financial lowering its price target, and ongoing concerns in the market reflected by mixed ratings from several analysts.

DaVita Inc. (DVA) stock declined by 2.01% following Principal Financial Group Inc.'s decision to reduce its holdings in the company and a downgrade in its target price by Truist Financial from $170 to $164, although the company reported better-than-expected quarterly earnings.

DaVita Inc. (DVA) stock rose by 0.6% following increases in institutional investments, with DekaBank trimming its stake while other firms like Invesco and Deutsche Bank boosted theirs, indicating strong confidence in the company's performance.

DaVita Inc. (NYSE:DVA) stock rose by 0.69% amid changes in institutional investors' positions, with positive earnings performance helping to sustain investor interest. The stock's increase can be attributed to a series of adjustments by institutional investors, including reductions and increases in shareholdings, as well as a strong quarterly earnings report that exceeded estimates, boosting investor confidence.

DaVita Inc. (NYSE:DVA) stock rose by 0.69% following significant increases in institutional investments, including a 17.8% stake increase by Vontobel Holding Ltd., and positive quarterly earnings results that exceeded analysts' expectations.

DaVita Inc. (DVA) stock was down 0.0% following a significant increase in institutional investment stakes, which may reflect market caution despite the company's robust earnings report and overall strong fundamentals.

DaVita Inc. (DVA) stock experienced a 0.52% increase, attributed to its recent strong earnings report that exceeded expectations and positive ratings adjustments from analysts, despite a generally cautious consensus rating of "Hold" among rating firms.

DaVita Inc. (NYSE:DVA) stock experienced a 0.85% increase following substantial growth in investments from hedge funds, with notable increases in holdings by various institutional investors, indicating strong market confidence in the company's financial performance and future prospects.

DaVita Inc. (DVA) stock rose by 0.85% following increased institutional investment activity, with SG Americas Securities and several other funds acquiring new stakes, as well as positive earnings results outperforming expectations.

DaVita Inc. (DVA) stock experienced a decline of 0.68%, despite an increase in holdings from institutional investors, likely due to a mixture of market sentiment and analysts adjusting their price targets and stock ratings, including some downgrades.

DaVita Inc. (NYSE:DVA) stock decreased by 0.24% following recent analyst activity that saw Truist Financial reduce its price target and recommend a "hold," amidst mixed recommendations from other brokerages and a quarterly earnings report that, although topped expectations, showed a year-over-year decline in earnings per share.

DaVita Inc. (DVA) stock fell by 1.65% likely due to mixed institutional investor activity, notable selling by Millennium Management, and revised price targets from analysts, reflecting a cautious outlook despite the company beating earnings estimates in its recent quarterly report.

DaVita (NYSE:DVA) stock rose by 0.56% following a strong quarterly earnings report, which beat consensus estimates with an EPS of $2.00 and a year-over-year revenue increase of 5%, despite a lowered target price from Truist Financial and mixed ratings from other research firms.

DaVita (NYSE:DVA) stock rose by 0

DaVita Inc. (DVA) stock declined by 0.23% following a slight reduction in its shares held by The Manufacturers Life Insurance Company and mixed sentiment from institutional investors, with most of them adjusting their positions in the company, reflecting cautious investor sentiment.

DaVita (DVA) stock declined by 0.78% likely due to Berkshire Hathaway's recent sale of nearly $148 million in DaVita shares to maintain ownership below a certain threshold, contributing to market concerns regarding the company's investment decisions amidst broader economic volatility.

DaVita (DVA) stock declined by 0

DaVita (DVA) stock rose by 0.01% ahead of its Q1 2025 earnings report, where analysts expect earnings and revenue to exceed previous estimates, and recent upgrades in stock ratings may have contributed to the increase.

DVA

Latest News & Analysis